Status:
COMPLETED
Study Comparing Moxidectin And Ivermectin In Subjects With Onchocerca Volvulus Infection
Lead Sponsor:
Medicines Development for Global Health
Collaborating Sponsors:
World Health Organization
Conditions:
Onchocerciasis
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
This is a Phase 3 study comparing the efficacy, safety and tolerability of moxidectin and ivermectin in subjects infected with Onchocerca volvulus, which is the parasite that causes river blindness. S...
Eligibility Criteria
Inclusion
- Male and female subjects with Onchocerca volvulus infection
Exclusion
- Pregnant or breast feeding women; coincidental loiasis
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
1497 Patients enrolled
Trial Details
Trial ID
NCT00790998
Start Date
April 1 2009
End Date
May 1 2012
Last Update
January 31 2018
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre de Recherche Clinique de Butembo - Université Catholique du Graben
Butembo, Democratic Republic of the Congo
2
Centre de Recherche en Maladies Tropicales de l'Ituri
Rethy, Democratic Republic of the Congo
3
Onchocerciasis Chemotherapy Research Center
Hohoe, Ghana
4
Liberian Institute for Biomedical Research Clinical Research Center
Bolahun, Lofa County, Liberia